Janus Henderson Group
London, Coloradojanushenderson.com
Overview
Janus Henderson Group is a global asset management firm formed through the 2017 merger of Janus Capital Group and Henderson Group, offering a range of financial products across equities, fixed income, multi-asset, and alternatives to individuals, intermediary advisors, and institutional investors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Draig Therapeutics | Jul 2026 | Series B | Co-investor |
| ARCYN Defense | Jul 2026 | Seed | Co-investor |
| Lycia Therapeutics | Jun 2026 | Series D | Lead |
| Serapha Bio | Jun 2026 | Series A | Co-investor |
| TriveniBio | Jun 2026 | Series C | Lead |
Key People
Myron Scholes
Chief Investment Strategist
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
